REQUEST A DEMO
Total
USD $0.00
Search more companies

Pb Pharma Bt. (Hungary)

Main Activities: Pharmacies and Drug Stores
Full name: pB pharma Gyogyszerinformacios es Kereskedelmi Bt. Profile Updated: July 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Hungarian Download a sample report

Pb Pharma Bt. is based in Hungary. The head office is in Pecs. The company operates in the Pharmacies and Drug Stores industry. The company was established on June 30, 1994. It currently has a total number of 11 (2024) employees. In 2023, the company reported a net sales revenue increase of 17.26%. During that time, Pb Pharma Bt.’s total assets grew by 19.2%. In 2023, Pb Pharma Bt.’s net profit margin decreased by 0.46%.

Headquarters
Zsolnay Vilmos u. 47/D
Pecs; Baranya; Postal Code: 7630

Contact Details: Purchase the Pb Pharma Bt. report to view the information.

Basic Information
Total Employees:
Purchase the Pb Pharma Bt. report to view the information.
Outstanding Shares:
Purchase the Pb Pharma Bt. report to view the information.
Registered Capital:
Purchase the Pb Pharma Bt. report to view the information.
Financial Auditors:
Purchase the Pb Pharma Bt. report to view the information.
Incorporation Date:
June 30, 1994
Key Executives
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Subsidiaries
UL-PA Ingatlanforgalmazasi es Kereskedelmi Kft.
Company Performance
Financial values in the chart are available after Pb Pharma Bt. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
17.26%
Total operating revenue
17.88%
Operating profit (EBIT)
-5.92%
EBITDA
-4.15%
Net Profit (Loss) for the Period
9.25%
Total assets
19.2%
Total equity
8.04%
Operating Profit Margin (ROS)
-1.49%
Net Profit Margin
-0.46%
Return on Equity (ROE)
0.22%
Quick Ratio
-0.13%
Cash Ratio
-0.2%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?